Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity - PubMed (original) (raw)
Review
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
David G DeNardo et al. Cancer Metastasis Rev. 2010 Jun.
Abstract
Tumor-associated myeloid cells have been implicated in regulating many of the "hallmarks of cancer" and thus fostering solid tumor development and metastasis. However, the same innate leukocytes also participate in anti-tumor immunity and restraint of malignant disease. While many factors regulate the propensity of myeloid cells to promote or repress cancerous growths, polarized adaptive immune responses by B and T lymphocytes have been identified as regulators of many aspects of myeloid cell biology by specifically regulating their functional capabilities. Here, we detail the diversity of heterogeneous B and T lymphocyte populations and their impacts on solid tumor development through their abilities to regulate myeloid cell function in solid tumors.
Figures
Fig. 1
Adaptive immune responses control tumor-associated myeloid cell bioactivity and tumor progression. Polarized responses by adaptive immune cells alter the balance between pro- and anti-tumor myeloid cell bioactivities. When the host’s response to neoplastic cell growth results in the production of TH1 cytokines by CD4+ T lymphocytes and NK cells, myeloid cells in turn induce programs promoting tumor regression and/or dormant disease. However, when these adaptive immune responses include chronic B lymphocyte activation and IgG production in combination with TH2 and TREG lymphocyte activation, programs of immune suppression, angiogenesis, tissue remodeling, and invasion are favored in myeloid cells and contribute to tumor progression and metastasis
Similar articles
- Lymphocytes in cancer development: polarization towards pro-tumor immunity.
Ruffell B, DeNardo DG, Affara NI, Coussens LM. Ruffell B, et al. Cytokine Growth Factor Rev. 2010 Feb;21(1):3-10. doi: 10.1016/j.cytogfr.2009.11.002. Epub 2009 Dec 11. Cytokine Growth Factor Rev. 2010. PMID: 20005150 Free PMC article. Review. - Signaling defects in anti-tumor T cells.
Frey AB, Monu N. Frey AB, et al. Immunol Rev. 2008 Apr;222:192-205. doi: 10.1111/j.1600-065X.2008.00606.x. Immunol Rev. 2008. PMID: 18364003 Free PMC article. Review. - Inflammatory cell infiltration of tumors: Jekyll or Hyde.
Talmadge JE, Donkor M, Scholar E. Talmadge JE, et al. Cancer Metastasis Rev. 2007 Dec;26(3-4):373-400. doi: 10.1007/s10555-007-9072-0. Cancer Metastasis Rev. 2007. PMID: 17717638 Review. - Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH, Beury DW, Ostrand-Rosenberg S. Parker KH, et al. Adv Cancer Res. 2015;128:95-139. doi: 10.1016/bs.acr.2015.04.002. Epub 2015 May 12. Adv Cancer Res. 2015. PMID: 26216631 Free PMC article. Review. - Functional Analysis of Tumor-Infiltrating Myeloid Cells by Flow Cytometry and Adoptive Transfer.
Nguyen A, Salem O, Wan Y. Nguyen A, et al. J Vis Exp. 2021 Mar 5;(169). doi: 10.3791/61511. J Vis Exp. 2021. PMID: 33749668
Cited by
- The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies.
Guo H, Xu X, Zhang J, Du Y, Yang X, He Z, Zhao L, Liang T, Guo L. Guo H, et al. Pharmaceuticals (Basel). 2024 Aug 9;17(8):1048. doi: 10.3390/ph17081048. Pharmaceuticals (Basel). 2024. PMID: 39204153 Free PMC article. Review. - The roles of tertiary lymphoid structures in genitourinary cancers: molecular mechanisms, therapeutic strategies, and clinical applications.
Yang J, Xiong X, Zheng W, Xu H, Liao X, Wei Q, Yang L. Yang J, et al. Int J Surg. 2024 Aug 1;110(8):5007-5021. doi: 10.1097/JS9.0000000000001939. Int J Surg. 2024. PMID: 38978471 Free PMC article. Review. - Detailed Profiling of the Tumor Microenvironment in Ethnic Breast Cancer, Using Tissue Microarrays and Multiplex Immunofluorescence.
Zaakouk M, Longworth A, Hunter K, Jiman S, Kearns D, El-Deftar M, Shaaban AM. Zaakouk M, et al. Int J Mol Sci. 2024 Jun 13;25(12):6501. doi: 10.3390/ijms25126501. Int J Mol Sci. 2024. PMID: 38928207 Free PMC article. - The Immune Response of Cutaneous Basosquamous- and Squamous-Cell Carcinoma Associated with Sun Exposure.
Grigore A, Oproiu AM, Iancu I, Florescu IP. Grigore A, et al. Curr Oncol. 2024 Apr 28;31(5):2481-2487. doi: 10.3390/curroncol31050185. Curr Oncol. 2024. PMID: 38785466 Free PMC article. - Tea intake and lung diseases: a Mendelian randomization study.
Wu Z, Jiao M, Shu C, Li C, Zhu Y. Wu Z, et al. Front Immunol. 2024 Feb 5;15:1328933. doi: 10.3389/fimmu.2024.1328933. eCollection 2024. Front Immunol. 2024. PMID: 38375474 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources